Phase 2 Adrenocortical Carcinoma Clinical Trials
8 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–8 of 8 trials
Recruiting
Phase 2
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
Colorectal, CancerCholangiocarcinomaColorectal Neoplasms+10 more
National Cancer Institute (NCI)70 enrolled1 locationNCT05286814
Recruiting
Phase 2
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
Adrenocortical CarcinomaACCMetastatic Adrenocortical Carcinoma
Memorial Sloan Kettering Cancer Center12 enrolled7 locationsNCT06066333
Recruiting
Phase 2
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
Soft Tissue SarcomaGastric AdenocarcinomaPancreatic Adenocarcinoma+5 more
UNICANCER120 enrolled22 locationsNCT06333314
Recruiting
Phase 2
Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
Peritoneal CarcinomatosisAdrenocortical Carcinoma
Columbia University30 enrolled1 locationNCT03127774
Recruiting
Phase 2
Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma
Adrenocortical Carcinoma
Sun Yat-sen University18 enrolled1 locationNCT06587802
Recruiting
Phase 2
Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.
Adrenocortical Carcinoma
Maria Sklodowska-Curie National Research Institute of Oncology24 enrolled4 locationsNCT05563467
Recruiting
Phase 2
Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)
Adrenocortical Carcinoma
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia80 enrolled1 locationNCT05913427
Recruiting
Phase 2
Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma
Adrenocortical Carcinoma
West China Hospital21 enrolled1 locationNCT04318730